Literature DB >> 16188712

Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.

Timothy E Wilens1, Anne Kwon, Sarah Tanguay, Rhea Chase, Hadley Moore, Stephen V Faraone, Joseph Biederman.   

Abstract

The objective of the study was to investigate the characteristics of adults with Attention Deficit Hyperactivity Disorder (ADHD) or substance use disorder (SUD), especially in the context of comorbid psychiatric disorders. Subjects were adults (n = 78) participating in a controlled family study of ADHD and SUD. Four groups were identified based on a diagnosis of ADHD or SUD: ADHD, SUD, ADHD + SUD, and neither ADHD nor SUD. All diagnoses were determined by structured clinical interview for DSM IV. Rates of psychiatric comorbidity were lowest in the controls, intermediate in the ADHD and SUD groups, and highest in the ADHD + SUD group. Relative to controls, the ADHD, SUD, and ADHD + SUD groups had higher rates of major depression (z = 1.98, p = 0.05), conduct disorder (z = 2.0, p = 0.04), antisocial personality disorder (z = 2.6, p = 0.009), agoraphobia (z = 2.5, p = 0.01) and social phobia (z = 2.7, p = 0.007). Higher rates of psychiatric comorbidity, especially mood and anxiety disorders, exist in subjects with SUD + ADHD relative to subjects with SUD, ADHD, or controls. Clinicians need to be attentive to other psychiatric disorders that may occur in the large group of adults with ADHD + SUD.

Entities:  

Mesh:

Year:  2005        PMID: 16188712     DOI: 10.1080/10550490591003639

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  17 in total

1.  Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.

Authors:  Katelijne van Emmerik-van Oortmerssen; Geurt van de Glind; Maarten W J Koeter; Steve Allsop; Marc Auriacombe; Csaba Barta; Eli Torild H Bu; Yuliya Burren; Pieter-Jan Carpentier; Susan Carruthers; Miguel Casas; Zsolt Demetrovics; Geert Dom; Stephen V Faraone; Melina Fatseas; Johan Franck; Brian Johnson; Máté Kapitány-Fövény; Sharlene Kaye; Maija Konstenius; Frances R Levin; Franz Moggi; Merete Møller; J Antoni Ramos-Quiroga; Arild Schillinger; Arvid Skutle; Sofie Verspreet; Wim van den Brink; Robert A Schoevers
Journal:  Addiction       Date:  2013-11-20       Impact factor: 6.526

Review 2.  Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?

Authors:  Pieter-Jan Carpentier; Frances R Levin
Journal:  Harv Rev Psychiatry       Date:  2017 Mar/Apr       Impact factor: 3.732

3.  Childhood trauma exposure in substance use disorder patients with and without ADHD.

Authors:  Maija Konstenius; Anders Leifman; Katelijne van Emmerik-van Oortmerssen; Geurt van de Glind; Johan Franck; Franz Moggi; Josep Antoni Ramos-Quiroga; Frances R Levin; Pieter Jan Carpentier; Arvid Skutle; Eli-Torild Bu; Sharlene Kaye; Zsolt Demetrovics; Csaba Barta; Marc Auriecomb; Melina Fatséas; Brian Johnson; Stephen V Faraone; Steve Allsop; Susan Carruthers; Robert A Schoevers; Sofie Verspreet; Geert Dom; Maarten W J Koeter; Wim van den Brink
Journal:  Addict Behav       Date:  2016-10-24       Impact factor: 3.913

4.  Methylphenidate treatment in the spontaneously hypertensive rat: influence on methylphenidate self-administration and reinstatement in comparison with Wistar rats.

Authors:  Ike dela Peña; Seo Young Yoon; Jong Chan Lee; June Bryan dela Peña; Aee Ree Sohn; Jong Hoon Ryu; Chan Young Shin; Jae Hoon Cheong
Journal:  Psychopharmacology (Berl)       Date:  2011-11-17       Impact factor: 4.530

Review 5.  Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders.

Authors:  Sean X Luo; Frances R Levin
Journal:  Curr Psychiatry Rep       Date:  2017-03       Impact factor: 5.285

Review 6.  Issues in the management of patients with complex attention-deficit hyperactivity disorder symptoms.

Authors:  Thomas J Spencer
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  Genome-wide linkage analysis in a Dutch multigenerational family with attention deficit hyperactivity disorder.

Authors:  Rinus Vegt; Aida M Bertoli-Avella; Joke H M Tulen; Bianca de Graaf; Annemieke J M H Verkerk; Jeroen Vervoort; Carla M Twigt; Anneke Maat-Kievit; Ruud van Tuijl; Marieke van der Lijn; Michiel W Hengeveld; Ben A Oostra
Journal:  Eur J Hum Genet       Date:  2009-08-26       Impact factor: 4.246

Review 8.  When ADHD and substance use disorders intersect: relationship and treatment implications.

Authors:  Timothy E Wilens; Steven Fusillo
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

9.  Human CLOCK gene-associated attention deficit hyperactivity disorder-related features in healthy adults: quantitative association study using Wender Utah Rating Scale.

Authors:  Seong Hoon Jeong; Je-Chun Yu; Chang Hwa Lee; Kyeong-Sook Choi; Jung-Eun Choi; Se Hyun Kim; Eun-Jeong Joo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-09-26       Impact factor: 5.270

10.  Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride.

Authors:  Rajasree Nair; Shannon B Moss
Journal:  Neuropsychiatr Dis Treat       Date:  2009-08-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.